29 results
Responsible body
CMDh Remove CMDh filter
-
List item
Press release: CMDh endorses new advice to minimise risk of next-morning impaired driving ability and mental alertness with zolpidem
CMDh, Last updated: 25/04/20142013 at the request of the Italian Medicines Agency (AIFA) under … was first conducted by the Pharmacovigilance Risk Assessment Committee … follow a review by the EMA’s Pharmacovigilance Risk Assessment Committee … -
List item
Press release: Restrictions in the use of flupirtine-containing medicines - CMDh endorses PRAC recommendation
CMDh, Last updated: 28/06/2013European Medicines Agency's Pharmacovigilance Risk Assessment Committee … follow a review by the EMA’s Pharmacovigilance Risk Assessment Committee … reviewed by your doctor or pharmacists. • Because flupirtine … -
List item
Press release: Restrictions on use of short-acting beta-agonists in obstetric indications – CMDh endorses PRAC recommendations
CMDh, Last updated: 25/10/2013European Medicines Agency's Pharmacovigilance Risk Assessment Committee … European Medicines Agency’s Pharmacovigilance Risk Assessment Committee … treatment, speak to your doctor or pharmacist. Information to healthcare … -
List item
Press release: Restrictions on use of codeine for pain relief in children – CMDh endorses PRAC recommendation
CMDh, Last updated: 28/06/2013European Medicines Agency's Pharmacovigilance Risk Assessment Committee … medicines by the EMA’s Pharmacovigilance Risk Assessment Committee … treatment, speak to your doctor or pharmacist. Information to healthcare … -
List item
Press release: Modified-release paracetamol-containing products to be suspended from EU market
CMDh, Last updated: 15/12/2017in medicines safety, the Pharmacovigilance Risk Assessment Committee … in medicines safety, the Pharmacovigilance Risk Assessment Committee … speak to your doctor or pharmacist about the best replacement … -
List item
Press release: Oral almitrine to be withdrawn by EU Member States
CMDh, Last updated: 31/05/2013Medicines Agency's (EMA's) Pharmacovigilance Risk Assessment Committee … Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee … speak to their doctor or pharmacist. Information to healthcare … -
List item
Press release: CMDh agrees to strengthen warnings on the use of valproate medicines in women and girls
CMDh, Last updated: 21/11/2014was conducted by the EMA's Pharmacovigilance and Risks Assessment Committee … conducted by the EMA’s Pharmacovigilance and Risks Assessment Committee … speak to your doctor or pharmacist. Information to healthcare … -
List item
Press release: New restrictions to minimise the risks of effects on heart rhythm with hydroxyzine-containing medicines
CMDh, Last updated: 27/03/2015originally made by EMA's Pharmacovigilance Risk Assessment Committee … originally made by EMA’s Pharmacovigilance Risk Assessment Committee … speak to their doctor or pharmacist. Information to healthcare … -
List item
Press release: Ambroxol and bromhexine expectorants: safety information to be updated
CMDh, Last updated: 27/02/2015originally made by EMA's Pharmacovigilance Risk Assessment Committee … originally made by EMA’s Pharmacovigilance Risk Assessment Committee … speak to your doctor of pharmacist. … -
List item
Press release: Benefits of Diane 35 and its generics outweigh risks in certain patient groups - PRAC recommendation endorsed by CMDh
CMDh, Last updated: 30/05/2013European Medicines Agency's Pharmacovigilance Risk Assessment Committee … European Medicines Agency’s Pharmacovigilance Risk Assessment Committee … should speak to your doctor or pharmacist. Information to healthcare … -
List item
Press release: No consistent evidence of an increased risk of heart problems with testosterone medicines
CMDh, Last updated: 21/11/2014follows a review by the EMA's Pharmacovigilance Risk Assessment Committee … follows a review by the EMA’s Pharmacovigilance Risk Assessment Committee … them with their doctor or pharmacist. Information to healthcare … -
List item
Press release: New safety advice for diclofenac – CMDh endorses PRAC recommendation
CMDh, Last updated: 28/06/2013European Medicines Agency's Pharmacovigilance Risk Assessment Committee … European Medicines Agency’s Pharmacovigilance Risk Assessment Committee … speak with your doctor or pharmacist. Information to healthcare … -
List item
Press release: CMDh confirms that methylprednisolone injections containing lactose must not be given to patients allergic to cow's milk proteins
CMDh, Last updated: 01/08/2017the recommendation of EMA's Pharmacovigilance Risk Assessment Committee … recommendation of EMA’s Pharmacovigilance Risk Assessment Committee … speak with your doctor or pharmacist. Information for healthcare … -
List item
Press release: Codeine not to be used in children below 12 years for cough and cold
CMDh, Last updated: 24/04/2015follow a review by EMA's Pharmacovigilance Risk Assessment Committee … follow a review by EMA’s Pharmacovigilance Risk Assessment Committee … treatment, speak to your doctor or pharmacist. Information for healthcare … -
List item
Press release: CMDh endorses recommendations to restrict the use of diacerein-containing medicines
CMDh, Last updated: 21/03/2014diacerein conducted by the EMA's Pharmacovigilance and Risk Assessment Committee … conducted by the EMA’s Pharmacovigilance and Risk Assessment Committee … please contact your doctor or pharmacist. Information to healthcare … -
List item
Press release: Hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients – CMDh endorses PRAC recommendations
CMDh, Last updated: 25/10/2013European Medicines Agency's Pharmacovigilance Risk Assessment Committee … European Medicines Agency’s Pharmacovigilance Risk Assessment Committee … speak to the treating doctor, pharmacist or nurse. Information … -
List item
Press release: Recommendation to suspend tetrazepam-containing medicines endorsed by CMDh
CMDh, Last updated: 29/04/2013recent recommendation by the Pharmacovigilance Risk Assessment Committee … recent recommendation by the Pharmacovigilance Risk Assessment Committee … alternative treatment. • Pharmacists should refer patients on … -
List item
Press release: CMDh endorses restricted use of bromocriptine for stopping breast milk production
CMDh, Last updated: 21/08/2014follows a review by the EMA's Pharmacovigilance Risk Assessment Committee … follows a review by the EMA’s Pharmacovigilance Risk Assessment Committee … should consult their doctor or pharmacist. Information to healthcare … -
List item
Press release: Updated advice on use of high-dose ibuprofen
CMDh, Last updated: 22/05/2015review carried out by EMA's Pharmacovigilance Risk Assessment Committee … review carried out by EMA’s Pharmacovigilance Risk Assessment Committee … advice of your doctor or pharmacist before using ibuprofen with … -
List item
Press release: Hydroxyethyl-starch solutions for infusion to be suspended – CMDh endorses PRAC recommendation
CMDh, Last updated: 26/01/2018been carried out by EMA's Pharmacovigilance Risk Assessment Committee … been carried out by EMA’s Pharmacovigilance Risk Assessment Committee … was first conducted by the Pharmacovigilance Risk Assessment Committee … -
List item
Press release: Acipimox only to be used as additional or alternative treatment to reduce high triglyceride levels
CMDh, Last updated: 20/12/2013European Medicines Agency's Pharmacovigilance Risk Assessment Committee … European Medicines Agency’s Pharmacovigilance Risk Assessment Committee … should ask their doctor or pharmacist. Information to healthcare … -
List item
Press release: Withdrawal of pain medicine flupirtine endorsed
CMDh, Last updated: 23/03/2018review, carried out by EMA's Pharmacovigilance Risk Assessment Committee … review, carried out by EMA’s Pharmacovigilance Risk Assessment Committee … first carried out by the Pharmacovigilance Risk Assessment Committee … -
List item
Press release: Restrictions in use of cyproterone due to meningioma risk
CMDh, Last updated: 27/03/2020treatment, talk to your doctor or pharmacist. … -
List item
Press release: CMDh endorses revocation of authorisations for fusafungine sprays used to treat airway infections
CMDh, Last updated: 01/04/2016follows a review by EMA's Pharmacovigilance Risk Assessment Committee … follows a review by EMA’s Pharmacovigilance Risk Assessment Committee … has been carried out by the Pharmacovigilance Risk Assessment Committee … -
List item
Press release: New measures to avoid valproate exposure in pregnancy endorsed
CMDh, Last updated: 23/03/2018The CMDh agreed with EMA's Pharmacovigilance Risk Assessment Committee … CMDh agreed with EMA’s Pharmacovigilance Risk Assessment Committee … to the packaging so that pharmacists can go through it with the …